Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedA new revision entry, v3.5.4, has been added to the study's history to replace the previous v3.5.3, indicating an administrative update to the record. This reflects an update to the documentation rather than any changes to the study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA minor update to the website’s revision/version label was made, changing the displayed revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the page history.SummaryDifference0.1%

- Check99 days agoChange DetectedA new Revision: v3.4.2 entry was added to the history, and older items such as the government funding notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.